Follow
del Caño-Ochoa, F
del Caño-Ochoa, F
IBV
Verified email at ibv.csic.es
Title
Cited by
Cited by
Year
Structural insight into the core of CAD, the multifunctional protein leading de novo pyrimidine biosynthesis
M Moreno-Morcillo, A Grande-García, A Ruiz-Ramos, F del Cano-Ochoa, ...
Structure 25 (6), 912-923. e5, 2017
512017
CAD, a multienzymatic protein at the head of de novo pyrimidine biosynthesis
F del Caño-Ochoa, M Moreno-Morcillo, S Ramón-Maiques
Macromolecular Protein Complexes II: Structure and Function, 505-538, 2019
302019
Deciphering CAD: Structure and function of a mega‐enzymatic pyrimidine factory in health and disease
F del Caño‐Ochoa, S Ramón‐Maiques
Protein Science 30 (10), 1995-2008, 2021
232021
Characterization of the catalytic flexible loop in the dihydroorotase domain of the human multi-enzymatic protein CAD
F del Caño-Ochoa, A Grande-García, M Reverte-López, M D’Abramo, ...
Journal of Biological Chemistry 293 (49), 18903-18913, 2018
212018
Mechanisms of feedback inhibition and sequential firing of active sites in plant aspartate transcarbamoylase
L Bellin, F Del Caño-Ochoa, A Velázquez-Campoy, T Möhlmann, ...
Nature communications 12 (1), 947, 2021
202021
Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy
F del Caño-Ochoa, BG Ng, M Abedalthagafi, M Almannai, RD Cohn, ...
Genetics in Medicine 22 (10), 1598-1605, 2020
192020
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver
N Hruschka, M Kalisz, M Subijana, O Graña-Castro, F Del Cano-Ochoa, ...
Oncogene 39 (32), 5455-5467, 2020
192020
Afatinib exerts immunomodulatory effects by targeting the pyrimidine biosynthesis enzyme CAD
HF Tu, CJ Ko, CT Lee, CF Lee, SW Lan, HH Lin, HY Lin, CC Ku, DY Lee, ...
Cancer Research 81 (12), 3270-3282, 2021
162021
Functional and structural deficiencies of Gemin5 variants associated with neurological disorders
R Francisco-Velilla, A Embarc-Buh, F del Caño-Ochoa, S Abellan, M Vilar, ...
Life Science Alliance 5 (7), 2022
82022
Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures
A Briso‐Montiano, F Del Caño‐Ochoa, A Vilas, A Velázquez‐Campoy, ...
Journal of Inherited Metabolic Disease 45 (2), 318-333, 2022
82022
Beyond genetics: Deciphering the impact of missense variants in CAD deficiency
F del Caño‐Ochoa, BG Ng, A Rubio‐del‐Campo, S Mahajan, MP Wilson, ...
Journal of inherited metabolic disease 46 (6), 1170-1185, 2023
62023
A functional platform for the selection of pathogenic variants of PMM2 amenable to rescue via the use of pharmacological chaperones
C Segovia‐Falquina, A Vilas, F Leal, F del Caño‐Ochoa, EP Kirk, ...
Human Mutation 43 (10), 1430-1442, 2022
42022
The multienzymatic protein CAD leading the de novo biosynthesis of pyrimidines localizes exclusively in the cytoplasm and does not translocate to the nucleus
F del Caño-Ochoa, S Ramón-Maiques
Nucleosides, Nucleotides & Nucleic Acids 39 (10-12), 1320-1334, 2020
42020
Phosphorylation of T897 in the dimerization domain of Gemin5 modulates protein interactions and translation regulation
R Francisco-Velilla, A Embarc-Buh, S Abellan, F del Caño-Ochoa, ...
Computational and Structural Biotechnology Journal 20, 6182-6191, 2022
32022
UMP inhibition and sequential firing in aspartate transcarbamoylase open ways to regulate plant growth
L Bellin, F del Caño-Ochoa, A Velázquez-Campoy, T Möhlmann, ...
bioRxiv, 2020.07. 17.208231, 2020
12020
Novel bi-allelic CAD variants cause epileptic encephalopathy responsive to triacetyluridine supplementation
K Anderson, K Wiltrout, C Giummo, SB Wortmann, H Freeze, ...
Molecular Genetics and Metabolism 141 (4), 108204, 2024
2024
Biallelic hypomorphic variants in CAD cause uridine‐responsive macrocytic anaemia with elevated haemoglobin‐A2
O Steinberg‐Shemer, J Yacobovich, S Noy‐Lotan, O Dgany, T Krasnov, ...
British Journal of Haematology 204 (3), 1067-1071, 2024
2024
A Tailored Strategy to Crosslink the Aspartate Transcarbamoylase Domain of the Multienzymatic Protein CAD
F del Caño-Ochoa, A Rubio-del-Campo, S Ramón-Maiques
Molecules 28 (2), 660, 2023
2023
Functional characterization of CAD, an antitumoral target controlling the de novo pyrimidine biosynthesis
F del Caño Ochoa
Universidad Autónoma de Madrid, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–19